TRANSLATE BIO, INC.
Profile
Company Names
TRANSLATE BIO, INC.
RANA THERAPEUTICS, INC.
Addresses
29 HARTWELL AVENUE, LEXINGTON, MA 02421
200 SIDNEY STREET, SUITE 310, CAMBRIDGE, MA 02139
Phone Numbers
617-945-7361
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2016
State Incorporated:
DELAWARE
Total Amount Raised:
$98,454,977.00
Number of Funding Rounds:
2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2019-05-03
$47,454,990.00
$47,454,990.00
$0.00
Equity
1
2016-12-22
$50,999,987.00
$50,999,987.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
DANIELLA
BECKMAN
DIRECTOR
JEAN-FRANCOIS
FORMELA
DIRECTOR
ARCA BIOPHARMA, INC.
| RESOLVYX PHARMACEUTICALS, INC.
| HORIZON PHARMA, INC.
| ANNOVATION BIOPHARMA, INC.
| ARTEAUS THERAPEUTICS, LLC
| COSTIM PHARMACEUTICALS INC.
| CALORICS, INC.
| NAVITOR PHARMACEUTICALS, INC.
| INTELLIA THERAPEUTICS, INC.
| IFM THERAPEUTICS, INC.
| SPERO THERAPEUTICS, LLC
| ATLAS VENTURE FUND XI, L.P.
| IFM TRE, INC.
| ATLAS VENTURE OPPORTUNITY FUND I, L.P.
| TRANSLATE BIO, INC.
| KORRO BIO, INC.
| IFM QUATTRO, INC.
| IFM CINQUE, INC.
| IFM CONTINUA, INC.
| ATLAS VENTURE FUND XII, L.P.
| SCORPION THERAPEUTICS, INC.
| SPERO THERAPEUTICS, INC.
| ATLAS VENTURE OPPORTUNITY FUND II, L.P.
| ATLAS VENTURE FUND XIII, L.P.
| AMAGMA, INC.
| IKENA ONCOLOGY, INC.
| ANTARES THERAPEUTICS, INC.
BRIAN
GALLAGHER
DIRECTOR
TRANSPORT PHARMACEUTICALS INC
| PROJECT MANAGEMENT HOLDINGS LTD
| SPRINGLEAF THERAPEUTICS, INC.
| RANA THERAPEUTICS, INC.
| CENTRAL IOWA LITHOTRIPSY, INC.
| RIVER VISION DEVELOPMENT CORP.
| COMMUNITY DEVELOPMENT TRUST INC
| CALCIMEDICA INC
| SPRINGBOT, INC.
| NAVITOR PHARMACEUTICALS, INC.
| RANA THERAPEUTICS, LLC
| TIER ONE HOLDING CORP.
| RANA THERAPEUTICS, INC.
| PACIFIC STREET FUND IV, L.P.
| SLATE BIO, INC.
OWEN
HUGHES
DIRECTOR
DANIEL
LYNCH
DIRECTOR
DANIEL
S.
LYNCH
DIRECTOR
THOMAS
MCCAULEY
EXECUTIVE OFFICER
RICHARD
WOOSTER
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2019-05-03
